文献速递遗传性与小管间质肾病肾小球疾病

阿拉伯半岛祖源以色列贝都因人中常染色体隐性多囊肾病的内含子及编码基因变异

Intronic and Coding Genetic Variants in Autosomal Recessive Polycystic Kidney Disease Among Israeli Bedouins of Arabian Peninsula Ancestry.
PubMed 文献 · Am J Kidney Dis · 2025-08-13

该病例系列对5个无关家族中12例标准遗传学分析未明确致病变异的阿拉伯半岛祖源以色列贝都因AR PKD患者行全基因组测序(含短读长和长读长平台)及转录分析,发现深内含子PKHD1变异(6:51,757,883 C>T,c.8643-2945 G>A),cDNA分析证实其经供体增益机制导致121碱基对假外显子插入并引入提前终止密码子,该变异在100名族裔匹配贝都因对照中2例携带(携带率1:50)。

要点

  • 深内含子PKHD1变异(c.8643-2945 G>A)为5个以色列内盖夫贝都因家族12例AR PKD患者的致病原因。
  • 该变异在100名族裔匹配贝都因对照中2例携带,携带率为1:50。
  • 尿源性肾小管上皮细胞cDNA分析证实121碱基对假外显子插入并引入提前终止密码子。

核心结论

  • 描述了一个深内含子截短型PKHD1变异,作为阿拉伯半岛祖源以色列贝都因人中导致AR PKD的常见奠基者变异。
  • 该PKHD1变异通过供体增益机制导致假外显子插入,而未直接引入剪接位点。
  • 这些发现凸显了全基因组测序和转录分析在识别致病性非编码AR PKD变异中的诊断效用。

研究设计与样本

  • 病例系列:12例来自5个无关家族的阿拉伯半岛祖源贝都因AR PKD患者,标准遗传学分析未明确致病变异。
  • 行全基因组测序(含短读长和长读长平台),随后进行生物信息学过滤和转录分析,并通过功能分析确认致病PKHD1变异。

主要发现

  • 在5个以色列内盖夫贝都因家族的12例AR PKD患者中识别出深内含子PKHD1变异(6:51,757,883 C>T(hg38),ENST00000340994.4:c.8643-2945 G>A)。
  • 该变异在受累家系中的分离符合常染色体隐性遗传。
  • 尿源性肾小管肾上皮细胞cDNA分析证实异常剪接伴121碱基对假外显子插入,引入提前终止密码子。
  • 该变异在100名族裔匹配贝都因对照个体中2例发现(携带率1:50)。
  • 在所有已知PKHD1剪接破坏性变异中,该变异在剪接预测工具中得分最低且最偏向良性。

关键数值与推荐

  • 深内含子PKHD1变异:6:51,757,883 C>T(hg38),ENST00000340994.4:c.8643-2945 G>A。
  • 携带率:100名族裔匹配贝都因对照中2例携带(1:50)。
  • cDNA分析:121碱基对假外显子插入,引入提前终止密码子。

临床怎么用

  • 原文结论指出全基因组测序和转录分析在识别致病性非编码AR PKD变异中具有诊断效用。
  • 通俗语言摘要指出该变异的检测可能成为该人群中AR PKD的有用筛查试验。

局限性

  • 功能研究仅限于尿源性上皮细胞。
  • 队列规模小。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Autosomal recessive polycystic kidney disease (ARPKD) is typically caused by biallelic PKHD1 variants. However, some patients with a clinical diagnosis remain without a molecular diagnosis. We identified cryptic pathogenic variants in Israeli Bedouin patients of Arabian Peninsula ancestry with ARPKD. STUDY DESIGN: Case series. SETTING & PARTICIPANTS: Twelve Bedouin patients of 5 unrelated families of Arabian Peninsula ancestry with ARPKD whose causative variant was unknown despite standard genetic analyses. OBSERVATIONS: Whole-genome sequencing (WGS), including short- and long-read platforms, followed by bioinformatics filtration and transcript analysis, identified a pathogenic PKHD1 variant confirmed by functional analysis: a deep-intronic PKHD1 variant (6:51,757,883 C>T (hg38), ENST00000340994.4: c.8643-2945 G>A) was identified in 12 patients with ARPKD within 5 families of Israeli Negev Bedouins originating from the Arabian Peninsula. Variant segregation within affected kindreds was consistent with autosomal recessive inheritance. Complementary DNA (cDNA) analysis of urine-derived tubular kidney epithelial cells confirmed aberrant splicing with pseudo-exon inclusion of 121 base pairs, introducing a premature stop codon. This variant was found in 2 of 100 ethnically matched Bedouin control individuals (carrier rate 1:50). Among all known PKHD1 splicing-disrupting variants, this variant received the lowest and most benign scores across splicing prediction tools. We also delineate 12 other PKHD1 variants in Negev Bedouins. LIMITATIONS: Functional studies were limited to urinary-derived epithelial cells, small cohort size. CONCLUSIONS: We describe a deep-intronic truncating PKHD1 variant, as a common founder variant causing ARPKD in Israeli Bedouins of Arabian Peninsula ancestry. This PKHD1 variant caused pseudo-exon inclusion through a donor-gain mechanism, without directly introducing a splice site. These findings highlight the diagnostic utility of WGS and transcript analysis in identifying pathogenic noncoding ARPKD variants. PLAIN-LANGUAGE SUMMARY: Autosomal recessive polycystic kidney disease (ARPKD) is a severe genetic disorder that affects the kidneys and liver, often presenting before birth. In some patients, standard genetic tests do not detect a causative variant. We examined affected families of Israeli Bedouins originating from the Arabian Peninsula and used whole-genome sequencing and RNA studies to search beyond the protein-coding regions of DNA. We discovered a variant deep within a noncoding region of the PKHD1 gene that interferes with RNA splicing and leads to disease. This variant is a common cause of ARPKD in this population, and its detection may be a useful screening test for ARPKD in this population. These findings highlight the potential importance of analyzing noncoding genomic regions and using population-specific data in genetic diagnosis.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Agam N, Wormser O, Biller A, et al. Intronic and Coding Genetic Variants in Autosomal Recessive Polycystic Kidney Disease Among Israeli Bedouins of Arabian Peninsula Ancestry. Am J Kidney Dis. 2025. PMID: 40816622. doi:10.1053/j.ajkd.2025.06.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。